CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Study to Evaluate Safety, PK and Biodistribution of an Imaging Agent, 18F-OP-801, After Intravenous Administration to Patients With ALS, Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease and Healthy Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05395624
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:50.818083+00:00
Published At: 2025-05-02T00:00:00+00:00
Record Updated At: 2025-05-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Amyotrophic Lateral Sclerosis (ALS)", "Parkinson Disease (PD)", "Alzheimer Disease (AD)", "Multiple Sclerosis (MS)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-02"
protocolSection.identificationModule.nctId: "NCT05395624"
protocolSection.identificationModule.officialTitle: "A Phase 1/2 Study to Evaluate Safety, PK and Biodistribution of an Imaging Agent, 18F-OP-801, After Intravenous Administration to Patients With ALS, Alzheimer\u0027s Disease, Multiple Sclerosis, Parkinson\u0027s Disease and Healthy Volunteers"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.